2007;87(4):1409-1439 2 Mller TD, Finan B, Clemmensen C, DiMarchi RD, Tschp MH
The work still happens naturally, but with better support behind it
Back to Journals Neuropsychiatric Disease and Treatment Volume 22 Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis Authors Kumar R , Hashempour Z, Shahriarirad S, Shahriarirad R, Hassett LC, Singh B , Croarkin PE , Veldic M, Frye MA, Pagali SR Received 6 January 2026 Accepted for publication 12 March 2026 Published 3 June 2026 Volume 2026:22 586506 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Roger Pinder Rakesh Kumar, 1 Zahra Hashempour, 2 Sara Shahriarirad, 2 Reza Shahriarirad, 3 Leslie C Hassett, 4 Balwinder Singh, 1 Paul E Croarkin, 1 Marin Veldic, 1 Mark A Frye, 1 Sandeep R Pagali 5 1 Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA
Acetyl-L-carnitine decreases glycation of lens proteins: in vitro studies Exp Eye Res 1999
Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials
Semaglutide is the active ingredient in Ozempic